Ali Hadizadeh Esfahani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Hadizadeh Esfahani has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Schuppert
RWTH Aachen University
9 shared publications - Lisa-Katrin Turnhoff
Joint Research Center for Computational Biomedicine, Rheinisch Westfälische Technische Hochschule Aachen, Aachen, Germany
5 shared publications Angelina Sverchkova
Joint Research Center for Computational Biomedicine (JRC-COMBINE), RWTH Aachen University, Faculty of Medicine, Aachen, Germany
2 shared publicationsAsis Hallab
IBG-4: Bioinformatics, Forschungszentrum Jülich, Jülich 52425, Germany
2 shared publicationsDavid Nevarez
Joint Research Center for Computational Biomedicine, RWTH Aachen University, Aachen 52074, Germany
2 shared publications- Julio Saez-Rodriguez
Faculty of Medicine, Heidelberg University, Heidelberg, Germany
2 shared publications
Latest Publications
- Open Access
Benchmarking Large Language AI Models Against Human Doctors Using an Emergency Medicine Simulation Approach
Background: Proper adoption of AI in emergency medicine necessitate thorough and rigorous appraisal. Classic benchmarks, which rely heavily on basic question-and-answer formats, though dominating the benchmarking field of LLM usage in medicine, have proven inadequate in assessing the full spectrum of skills incumbent upon an agent in healthcare. Methods: We propose an intricate benchmarking scheme in which the skill set required of an emergency physician is tested and quantified. Our benchmarking structure is 3-fold: skills such as history taking, diagnostic accuracy, treatment plan, and empathy are evaluated by an emergency medicine expert, while the same expertise is scored by an intern from the perspective of a patient, through what we call a simulated emergency room visit. A comprehensive written examination is also utilized to measure general emergency medicine knowledge. Results: Eight LLMs were benchmarked against each other and in contrast to nine emergency medical doctors. Our findings indicate that the AI models significantly outperformed human physicians across several key domains, including history taking, investigation, diagnostic accuracy, and treatment planning. Furthermore, the models demonstrated superior performance in comprehensibility, credibility, and empathy. When comparing AI models against each other, performance advantages were marginal during simulated emergency room visits and were mostly pronounced during the written examination. Conclusion: AI models demonstrate a clear advantage over human physicians across a diverse range of emergency medicine competencies. The proposed benchmarking scheme provides a comprehensive metric for a thorough evaluation of medical skill set, furthering validation, adaptation, and utilization of AI in emergency medicine.
Open AccessBenchmarking Large Language AI Models Against Human Doctors Using an Emergency Medicine Simulation Approach
Background: Proper adoption of AI in emergency medicine necessitate thorough and rigorous appraisal. Classic benchmarks, which rely heavily on basic question-and-answer formats, though dominating the benchmarking field of LLM usage in medicine, have proven inadequate in assessing the full spectrum of skills incumbent upon an agent in healthcare. Methods: We propose an intricate benchmarking scheme in which the skill set required of an emergency physician is tested and quantified. Our benchmarking structure is 3-fold: skills such as history taking, diagnostic accuracy, treatment plan, and empathy are evaluated by an emergency medicine expert, while the same expertise is scored by an intern from the perspective of a patient, through what we call a simulated emergency room visit. A comprehensive written examination is also utilized to measure general emergency medicine knowledge. Results: Eight LLMs were benchmarked against each other and in contrast to nine emergency medical doctors. Our findings indicate that the AI models significantly outperformed human physicians across several key domains, including history taking, investigation, diagnostic accuracy, and treatment planning. Furthermore, the models demonstrated superior performance in comprehensibility, credibility, and empathy. When comparing AI models against each other, performance advantages were marginal during simulated emergency room visits and were mostly pronounced during the written examination. Conclusion: AI models demonstrate a clear advantage over human physicians across a diverse range of emergency medicine competencies. The proposed benchmarking scheme provides a comprehensive metric for a thorough evaluation of medical skill set, furthering validation, adaptation, and utilization of AI in emergency medicine.
- Open Access
- 17 July 2021
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 187 (3) , 1795-1811
Plant PhysioSpace: a robust tool to compare stress response across plant species
Generalization of transcriptomics results can be achieved by comparison across experiments. This generalization is based on integration of interrelated transcriptomics studies into a compendium. Such a focus on the bigger picture enables both characterizations of the fate of an organism and distinction between generic and specific responses. Numerous methods for analyzing transcriptomics datasets exist. Yet, most of these methods focus on gene-wise dimension reduction to obtain marker genes and gene sets for, for example, pathway analysis. Relying only on isolated biological modules might result in missing important confounders and relevant contexts. We developed a method called Plant PhysioSpace, which enables researchers to compute experimental conditions across species and platforms without a priori reducing the reference information to specific gene sets. Plant PhysioSpace extracts physiologically relevant signatures from a reference dataset (i.e. a collection of public datasets) by integrating and transforming heterogeneous reference gene expression data into a set of physiology-specific patterns. New experimental data can be mapped to these patterns, resulting in similarity scores between the acquired data and the extracted compendium. Because of its robustness against platform bias and noise, Plant PhysioSpace can function as an inter-species or cross-platform similarity measure. We have demonstrated its success in translating stress responses between different species and platforms, including single-cell technologies. We have also implemented two R packages, one software and one data package, and a Shiny web application to facilitate access to our method and precomputed models.
- 17 July 2021
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 187 (3) , 1795-1811
Open AccessPlant PhysioSpace: a robust tool to compare stress response across plant species
Generalization of transcriptomics results can be achieved by comparison across experiments. This generalization is based on integration of interrelated transcriptomics studies into a compendium. Such a focus on the bigger picture enables both characterizations of the fate of an organism and distinction between generic and specific responses. Numerous methods for analyzing transcriptomics datasets exist. Yet, most of these methods focus on gene-wise dimension reduction to obtain marker genes and gene sets for, for example, pathway analysis. Relying only on isolated biological modules might result in missing important confounders and relevant contexts. We developed a method called Plant PhysioSpace, which enables researchers to compute experimental conditions across species and platforms without a priori reducing the reference information to specific gene sets. Plant PhysioSpace extracts physiologically relevant signatures from a reference dataset (i.e. a collection of public datasets) by integrating and transforming heterogeneous reference gene expression data into a set of physiology-specific patterns. New experimental data can be mapped to these patterns, resulting in similarity scores between the acquired data and the extracted compendium. Because of its robustness against platform bias and noise, Plant PhysioSpace can function as an inter-species or cross-platform similarity measure. We have demonstrated its success in translating stress responses between different species and platforms, including single-cell technologies. We have also implemented two R packages, one software and one data package, and a Shiny web application to facilitate access to our method and precomputed models.
- Open Access
Plant PhysioSpace: a robust tool to compare stress response across plant species
Generalization of transcriptomics results can be achieved by comparison across experiments, which is based on integration of interrelated transcriptomics studies into a compendium. Both characterization of the fate of the organism under study as well as distinguishing between generic and specific responses can be gained in such a broader context. We have built such a compendium for plant stress response, which is based on integrating publicly available data sets for plant stress response to generalize results across studies and extract the most robust and meaningful information possible from them. There are numerous methods and tools to analyze such data sets, most focusing on gene-wise dimension reduction of data to obtain marker genes and gene sets, e.g. for pathway analysis. Relying only on isolated biological modules might lead to missing of important confounders and relevant context. Therefore, we have chosen a different approach: Our novel tool, which we called Plant PhysioSpace, provides the ability to compute experimental conditions across species and platforms without a priori reducing the reference information to specific gene-sets. It extracts physiologically relevant signatures from a reference data set, a collection of public data sets, by integrating and transforming heterogeneous reference gene expression data into a set of physiology-specific patterns, called PhysioSpace. New experimental data can be mapped to these PhysioSpaces, resulting in similarity scores, providing quantitative similarity of the new experiment to an a priori compendium. Here we report the implementation of two R packages, one software and one data package, and a shiny web application, which provides plant biologists convenient ways to access the method and a precomputed compendium of more than 900 PhysioSpace basis vectors from 4 different species (Arabidopsis thaliana, Oryza sativa, Glycine max, and Triticum aestivum). The tool reduces the dimensionality of data sample-wise (and not gene-wise), which results in a vector containing all genes. This method is very robust against noise and change of platform while still being sensitive. Plant PhysioSpace can therefore be used as an inter-species or cross-platform similarity measure. We demonstrate that Plant PhysioSpace can successfully translate stress responses between different species and platforms (including single cell technologies).
Open AccessPlant PhysioSpace: a robust tool to compare stress response across plant species
Generalization of transcriptomics results can be achieved by comparison across experiments, which is based on integration of interrelated transcriptomics studies into a compendium. Both characterization of the fate of the organism under study as well as distinguishing between generic and specific responses can be gained in such a broader context. We have built such a compendium for plant stress response, which is based on integrating publicly available data sets for plant stress response to generalize results across studies and extract the most robust and meaningful information possible from them. There are numerous methods and tools to analyze such data sets, most focusing on gene-wise dimension reduction of data to obtain marker genes and gene sets, e.g. for pathway analysis. Relying only on isolated biological modules might lead to missing of important confounders and relevant context. Therefore, we have chosen a different approach: Our novel tool, which we called Plant PhysioSpace, provides the ability to compute experimental conditions across species and platforms without a priori reducing the reference information to specific gene-sets. It extracts physiologically relevant signatures from a reference data set, a collection of public data sets, by integrating and transforming heterogeneous reference gene expression data into a set of physiology-specific patterns, called PhysioSpace. New experimental data can be mapped to these PhysioSpaces, resulting in similarity scores, providing quantitative similarity of the new experiment to an a priori compendium. Here we report the implementation of two R packages, one software and one data package, and a shiny web application, which provides plant biologists convenient ways to access the method and a precomputed compendium of more than 900 PhysioSpace basis vectors from 4 different species (Arabidopsis thaliana, Oryza sativa, Glycine max, and Triticum aestivum). The tool reduces the dimensionality of data sample-wise (and not gene-wise), which results in a vector containing all genes. This method is very robust against noise and change of platform while still being sensitive. Plant PhysioSpace can therefore be used as an inter-species or cross-platform similarity measure. We demonstrate that Plant PhysioSpace can successfully translate stress responses between different species and platforms (including single cell technologies).
- Open Access
- 20 April 2020
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 16 (4) , e1007803
Methodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE
Translational models directly relating drug response specific processes that can be observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, current studies often focus on the optimization of isolated model characteristics instead of examining the overall modeling workflow and the interplay of the individual model components. Moreover, they are often limited to specific data sets only. Therefore, they are often confined by the irreproducibility of the results and the non-transferability of the approaches into other contexts. In this study, we present a thorough investigation of translational models and their ability to predict the drug responses of cancer patients originating from diverse data sets using the R-package FORESEE. By systematically scanning the modeling space for optimal combinations of different model settings, we can determine models of extremely high predictivity and work out a few modeling guidelines that promote simplicity. Yet, we identify noise within the data, sample size effects, and drug unspecificity as factors that deteriorate the models’ robustness. Moreover, we show that cell line models of high accuracy do not necessarily excel in predicting drug response processes in patients. We therefore hope to motivate future research to consider in vivo aspects more carefully to ultimately generate deeper insights into applicable precision medicine. In the context of personalized medicine, finding genomic patterns in a cancer patient that can predict how a specific drug will affect the patient’s survival is of great interest. Translational approaches that directly relate drug response specific processes observed in cell line experiments to their role in cancer patients have the potential to increase the clinical relevance of models. Unfortunately, existing approaches are often irreproducible in other applications. In order to address this irreproducibility aspect, our work comprises a thorough investigation of a diverse set of translational models. In contrast to other approaches that focus on one isolated model characteristic at a time, we examine the overall workflow and the interplay of all model components. Additionally, we validate our models in multiple patient data sets and identify differences between cell line and patient models. While we can establish models of high predictive performance, we also expose the deceptive potential of optimizing methods to a specific use case only by showing that those models do not necessarily depict biological processes. Thus, this study serves as a guide to interpret new approaches in a broader context to avoid the dissemination of noise-driven models that fail to serve in everyday applications.
- 20 April 2020
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 16 (4) , e1007803
Open AccessMethodological challenges in translational drug response modeling in cancer: A systematic analysis with FORESEE
Translational models directly relating drug response specific processes that can be observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, current studies often focus on the optimization of isolated model characteristics instead of examining the overall modeling workflow and the interplay of the individual model components. Moreover, they are often limited to specific data sets only. Therefore, they are often confined by the irreproducibility of the results and the non-transferability of the approaches into other contexts. In this study, we present a thorough investigation of translational models and their ability to predict the drug responses of cancer patients originating from diverse data sets using the R-package FORESEE. By systematically scanning the modeling space for optimal combinations of different model settings, we can determine models of extremely high predictivity and work out a few modeling guidelines that promote simplicity. Yet, we identify noise within the data, sample size effects, and drug unspecificity as factors that deteriorate the models’ robustness. Moreover, we show that cell line models of high accuracy do not necessarily excel in predicting drug response processes in patients. We therefore hope to motivate future research to consider in vivo aspects more carefully to ultimately generate deeper insights into applicable precision medicine. In the context of personalized medicine, finding genomic patterns in a cancer patient that can predict how a specific drug will affect the patient’s survival is of great interest. Translational approaches that directly relate drug response specific processes observed in cell line experiments to their role in cancer patients have the potential to increase the clinical relevance of models. Unfortunately, existing approaches are often irreproducible in other applications. In order to address this irreproducibility aspect, our work comprises a thorough investigation of a diverse set of translational models. In contrast to other approaches that focus on one isolated model characteristic at a time, we examine the overall workflow and the interplay of all model components. Additionally, we validate our models in multiple patient data sets and identify differences between cell line and patient models. While we can establish models of high predictive performance, we also expose the deceptive potential of optimizing methods to a specific use case only by showing that those models do not necessarily depict biological processes. Thus, this study serves as a guide to interpret new approaches in a broader context to avoid the dissemination of noise-driven models that fail to serve in everyday applications.
- Open Access
Methodological Challenges in Translational Drug Response Modeling in Cancer
Translational models directly relating drug response-specific processes observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, ongoing research is often confined by the irreproducibility of the results in other contexts. While the inconsistency of pharmacological data has received great attention recently, the computational aspect of this crisis still deserves closer examination. Notably, studies often focus only on isolated model characteristics instead of examining the overall workflow and the interplay of individual model components. Here, we present a systematic investigation of translational models using the R-package FORESEE. Our findings confirm that with the current exploitation of the available data and the prevailing trend of optimizing methods to only one specific use case, modeling solutions will continue to suffer from non-transferability. Instead, the conduct of developing translational approaches urgently needs to change to retrieve clinical relevance in the future.
Open AccessMethodological Challenges in Translational Drug Response Modeling in Cancer
Translational models directly relating drug response-specific processes observed in vitro to their in vivo role in cancer patients constitute a crucial part of the development of personalized medication. Unfortunately, ongoing research is often confined by the irreproducibility of the results in other contexts. While the inconsistency of pharmacological data has received great attention recently, the computational aspect of this crisis still deserves closer examination. Notably, studies often focus only on isolated model characteristics instead of examining the overall workflow and the interplay of individual model components. Here, we present a systematic investigation of translational models using the R-package FORESEE. Our findings confirm that with the current exploitation of the available data and the prevailing trend of optimizing methods to only one specific use case, modeling solutions will continue to suffer from non-transferability. Instead, the conduct of developing translational approaches urgently needs to change to retrieve clinical relevance in the future.
- 12 June 2019
- Published by Springer Nature
- p. 269-295
Metastable Regimes and Tipping Points of Biochemical Networks with Potential Applications in Precision Medicine
- 12 June 2019
- Published by Springer Nature
- p. 269-295
Metastable Regimes and Tipping Points of Biochemical Networks with Potential Applications in Precision Medicine
- Open Access
- 1 March 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (19) , 3846-3848
FORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient datasets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art pre-processing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE and https://doi.org/10.17605/OSF.IO/RF6QK, and provides vignettes for documentation and application both online and in the Supplementary Files 2 and 3. Supplementary data are available at Bioinformatics online.
- 1 March 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (19) , 3846-3848
Open AccessFORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient datasets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art pre-processing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE and https://doi.org/10.17605/OSF.IO/RF6QK, and provides vignettes for documentation and application both online and in the Supplementary Files 2 and 3. Supplementary data are available at Bioinformatics online.
- Open Access
- 11 February 2019
- Published by PeerJ in PeerJ Preprints
FORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient data sets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art preprocessing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. Availability and Implementation: FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE . Supplementary Information: Supplementary Files 1 and 2 provide detailed descriptions of the pipeline and the data preparation process, while Supplementary File 3 presents basic use cases of the package. Contact: schuppert@combine.rwth-aachen.de
- 11 February 2019
- Published by PeerJ in PeerJ Preprints
Open AccessFORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient data sets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art preprocessing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. Availability and Implementation: FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE . Supplementary Information: Supplementary Files 1 and 2 provide detailed descriptions of the pipeline and the data preparation process, while Supplementary File 3 presents basic use cases of the package. Contact: schuppert@combine.rwth-aachen.de
- Open Access
- 4 October 2018
- Published by PeerJ in PeerJ Preprints
FORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient data sets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art preprocessing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. Availability and Implementation: FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE . Supplementary Information: Supplementary Files 1 and 2 provide detailed descriptions of the pipeline and the data preparation process, while Supplementary File 3 presents basic use cases of the package. Contact: schuppert@combine.rwth-aachen.de
- 4 October 2018
- Published by PeerJ in PeerJ Preprints
Open AccessFORESEE: a tool for the systematic comparison of translational drug response modeling pipelines
Translational models that utilize omics data generated in in vitro studies to predict the drug efficacy of anti-cancer compounds in patients are highly distinct, which complicates the benchmarking process for new computational approaches. In reaction to this, we introduce the uniFied translatiOnal dRug rESponsE prEdiction platform FORESEE, an open-source R-package. FORESEE not only provides a uniform data format for public cell line and patient data sets, but also establishes a standardized environment for drug response prediction pipelines, incorporating various state-of-the-art preprocessing methods, model training algorithms and validation techniques. The modular implementation of individual elements of the pipeline facilitates a straightforward development of combinatorial models, which can be used to re-evaluate and improve already existing pipelines as well as to develop new ones. Availability and Implementation: FORESEE is licensed under GNU General Public License v3.0 and available at https://github.com/JRC-COMBINE/FORESEE . Supplementary Information: Supplementary Files 1 and 2 provide detailed descriptions of the pipeline and the data preparation process, while Supplementary File 3 presents basic use cases of the package. Contact: schuppert@combine.rwth-aachen.de
- Open Access
- 2 January 2018
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 14 (1) , e1005890
A systematic atlas of chaperome deregulation topologies across the human cancer landscape
Proteome balance is safeguarded by the proteostasis network (PN), an intricately regulated network of conserved processes that evolved to maintain native function of the diverse ensemble of protein species, ensuring cellular and organismal health. Proteostasis imbalances and collapse are implicated in a spectrum of human diseases, from neurodegeneration to cancer. The characteristics of PN disease alterations however have not been assessed in a systematic way. Since the chaperome is among the central components of the PN, we focused on the chaperome in our study by utilizing a curated functional ontology of the human chaperome that we connect in a high-confidence physical protein-protein interaction network. Challenged by the lack of a systems-level understanding of proteostasis alterations in the heterogeneous spectrum of human cancers, we assessed gene expression across more than 10,000 patient biopsies covering 22 solid cancers. We derived a novel customized Meta-PCA dimension reduction approach yielding M-scores as quantitative indicators of disease expression changes to condense the complexity of cancer transcriptomics datasets into quantitative functional network topographies. We confirm upregulation of the HSP90 family and also highlight HSP60s, Prefoldins, HSP100s, ER- and mitochondria-specific chaperones as pan-cancer enriched. Our analysis also reveals a surprisingly consistent strong downregulation of small heat shock proteins (sHSPs) and we stratify two cancer groups based on the preferential upregulation of ATP-dependent chaperones. Strikingly, our analyses highlight similarities between stem cell and cancer proteostasis, and diametrically opposed chaperome deregulation between cancers and neurodegenerative diseases. We developed a web-based Proteostasis Profiler tool (Pro2) enabling intuitive analysis and visual exploration of proteostasis disease alterations using gene expression data. Our study showcases a comprehensive profiling of chaperome shifts in human cancers and sets the stage for a systematic global analysis of PN alterations across the human diseasome towards novel hypotheses for therapeutic network re-adjustment in proteostasis disorders. Protein homeostasis, or proteostasis, is maintained by the proteostasis network (PN), an intricately regulated modular network of interacting processes that evolved to balance the native proteome, supporting cellular and organismal health throughout lifespan. Imbalances and collapse of cellular proteostasis capacity, the capacity to buffer against cytotoxic damage and stress, is increasingly implicated in some of the most challenging diseases of our time, including neurodegeneration and cancers. The systems-level PN alterations in these diseases are not understood to date. Here, we address this challenge, focussing on the human chaperome, the ensemble of chaperones and co-chaperones, which represents a central conserved PN functional arm. We devised a novel data dimensionality reduction approach enabling quantitative contextual visualization of chaperome alterations in the heterogeneous spectrum of cancers based on gene expression data from thousands of patient biopsies. We developed Proteostasis Profiler (Pro2), a new web-tool enabling intuitive visualisation of cancer chaperome deregulation maps. We stratify two cancer groups based on diverging chaperome deregulation and highlight similarities between cancer and stem cell proteostasis. Our study also exposes drastically opposed shifts between cancers and neurodegenerative diseases. Collectively, this study sets the stage for a systematic global analysis of PN alterations across the human diseasome.
- 2 January 2018
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 14 (1) , e1005890
Open AccessA systematic atlas of chaperome deregulation topologies across the human cancer landscape
Proteome balance is safeguarded by the proteostasis network (PN), an intricately regulated network of conserved processes that evolved to maintain native function of the diverse ensemble of protein species, ensuring cellular and organismal health. Proteostasis imbalances and collapse are implicated in a spectrum of human diseases, from neurodegeneration to cancer. The characteristics of PN disease alterations however have not been assessed in a systematic way. Since the chaperome is among the central components of the PN, we focused on the chaperome in our study by utilizing a curated functional ontology of the human chaperome that we connect in a high-confidence physical protein-protein interaction network. Challenged by the lack of a systems-level understanding of proteostasis alterations in the heterogeneous spectrum of human cancers, we assessed gene expression across more than 10,000 patient biopsies covering 22 solid cancers. We derived a novel customized Meta-PCA dimension reduction approach yielding M-scores as quantitative indicators of disease expression changes to condense the complexity of cancer transcriptomics datasets into quantitative functional network topographies. We confirm upregulation of the HSP90 family and also highlight HSP60s, Prefoldins, HSP100s, ER- and mitochondria-specific chaperones as pan-cancer enriched. Our analysis also reveals a surprisingly consistent strong downregulation of small heat shock proteins (sHSPs) and we stratify two cancer groups based on the preferential upregulation of ATP-dependent chaperones. Strikingly, our analyses highlight similarities between stem cell and cancer proteostasis, and diametrically opposed chaperome deregulation between cancers and neurodegenerative diseases. We developed a web-based Proteostasis Profiler tool (Pro2) enabling intuitive analysis and visual exploration of proteostasis disease alterations using gene expression data. Our study showcases a comprehensive profiling of chaperome shifts in human cancers and sets the stage for a systematic global analysis of PN alterations across the human diseasome towards novel hypotheses for therapeutic network re-adjustment in proteostasis disorders. Protein homeostasis, or proteostasis, is maintained by the proteostasis network (PN), an intricately regulated modular network of interacting processes that evolved to balance the native proteome, supporting cellular and organismal health throughout lifespan. Imbalances and collapse of cellular proteostasis capacity, the capacity to buffer against cytotoxic damage and stress, is increasingly implicated in some of the most challenging diseases of our time, including neurodegeneration and cancers. The systems-level PN alterations in these diseases are not understood to date. Here, we address this challenge, focussing on the human chaperome, the ensemble of chaperones and co-chaperones, which represents a central conserved PN functional arm. We devised a novel data dimensionality reduction approach enabling quantitative contextual visualization of chaperome alterations in the heterogeneous spectrum of cancers based on gene expression data from thousands of patient biopsies. We developed Proteostasis Profiler (Pro2), a new web-tool enabling intuitive visualisation of cancer chaperome deregulation maps. We stratify two cancer groups based on diverging chaperome deregulation and highlight similarities between cancer and stem cell proteostasis. Our study also exposes drastically opposed shifts between cancers and neurodegenerative diseases. Collectively, this study sets the stage for a systematic global analysis of PN alterations across the human diseasome.